Suppr超能文献

意大利临床新型隐球菌 var. grubii 分离株的分子流行病学研究。

Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates.

机构信息

Lab. Micologia Medica, Dip. Scienze Biomediche per la Salute, Università degli Studi di Milano, Milano, Italy.

出版信息

Med Mycol. 2013 Jul;51(5):499-506. doi: 10.3109/13693786.2012.751642. Epub 2013 Jan 4.

Abstract

Cryptococcus neoformans variety grubii is the major etiological agent of cryptococcal meningitis in both immunocompromised and immunocompetent patients. The current PCR-based molecular methods are not sufficient to discriminate among the different populations of this yeast. Therefore, the aim of the present study was to investigate the genotypes of the Italian clinical C. neoformans var. grubii isolates by multilocus sequence typing (MLST). A total of 53 isolates, each representative of a single case, were studied. Genotyping was performed using the ISHAM Cryptococcus MLST consensus scheme and the results were compared to the publically available global C. neoformans var. grubii MLST dataset. A total of 16 genotypes were identified; 14 were new genotypes, one was identical to sequence type (ST) ST81, which had been previously reported from Thailand, and one to ST23 already identified in Uganda, the USA and Korea. Sequence type ST61 was the most numerous, including 16 isolates. Network phylogenetic analysis showed that the Italian isolates could be divided into at least three clusters with similarities with those recovered in Africa, Asia and Americas. Distribution of the STs among the isolates could not be correlated to the hospital in which they were recovered or to the HIV status of the patients. The majority of the isolates belonged to the molecular type VNI; three belonged to the rare molecular type VNII and one to the VNB group, which until now had not been described in Europe. The results reveal that the Italian C. neoformans var. grubii population presents a distinct variability, displaying a high number of new genotypes, and probably recombines sexually.

摘要

新型隐球菌格株是免疫功能低下和免疫功能正常患者发生隐球菌性脑膜炎的主要病原体。目前基于 PCR 的分子方法不足以区分该酵母的不同群体。因此,本研究旨在通过多位点序列分型(MLST)来研究意大利临床新型隐球菌格株分离株的基因型。共研究了 53 株分离株,每株均代表一个单一病例。使用 ISHAM 隐球菌 MLST 共识方案进行基因分型,并将结果与公开的全球新型隐球菌格株 MLST 数据集进行比较。共鉴定出 16 种基因型;其中 14 种是新的基因型,一种与先前从泰国报道的序列型(ST)ST81 相同,一种与已在乌干达、美国和韩国发现的 ST23 相同。ST61 是数量最多的序列型,包括 16 个分离株。网络系统发育分析表明,意大利分离株可分为至少三个群,与非洲、亚洲和美洲分离株相似。ST 在分离株中的分布与它们被分离的医院或患者的 HIV 状态无关。大多数分离株属于分子型 VNI;三种属于罕见的分子型 VNII,一种属于 VNB 组,到目前为止,该组在欧洲尚未被描述。结果表明,意大利新型隐球菌格株种群具有明显的变异性,表现出大量新的基因型,可能存在性重组。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验